Search Results
Results found for "Yao (Jackie) Lu"
- đź“° GPCR Weekly News, August 21 to 27, 2023
Sudarshan Rajagopal and their lab team study on 'Location bias: A "Hidden Variable" in GPCR pharmacology' Yao Lu and colleagues work on 'Molecular insights into orphan GPCRs relevant to schizophrenia' Carole Daly
- đź“° GPCR Weekly News, July 1 to 7, 2024
Jianming Han, Tao Che for their analysis of GPCR-G protein selectivity revealed by structural pharmacology Yao Lu, Drs Christopher Langmead, Gregory Stewart, et al. for their study on Molecular insights into orphan
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
proteins (Gether 2000), with numerous intermediate sub-states in between (Vauquelin and Van Liefde 2005; Yao 1984 (Cerione et al. 1984), where reconstitution of purified β2-adrenergic receptors from guinea pig lung
- Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet
August 2022 Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based In this regard, luminescence-based biosensors have revolutionized our ability to monitor GPCR signaling We found that preincubation and luminescence reading at room temperature were optimal as compared to
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
After discussing the fundamentals and applications of mutagenesis in GPCR studies (Lu, 2024), a case Reference Cam Sinh Lu. (2024, September 3).
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
factors, including ETS, c-Jun, and Fos, modulating gene expression and influencing cellular functions (Lu Lu, N., & Malemud, C. J. (2019). S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003).
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
This Week’s Highlights: Congrats to: Our contributor, Cam Sinh Lu ,  who has just released an incredible team: Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China M Payne ,  Cam Sinh Lu
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Jang W, Senarath K, Feinberg G, Lu S, Lambert NA.
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
This Week’s Highlights: Harnessing Deep Mutational Scanning for Enhanced Drug Discovery Cam Sinh Lu
- đź“° GPCR Weekly News, May 20 to 26, 2024
This week's highlight includes congrats to: Cam Sinh Lu, for his first Dr.
- Structural landscape of the Chemokine Receptor system
TM7 and the intracellular helix 8 move outward from the receptor core to make room for the G-protein (Lu constitutively active receptors, meaning they can signal independently of agonist (Casarosa, Bakker et al. 2001, Luker recycling of chemokines without activating G-protein pathways (Randolph-Habecker, Rahill et al. 2002, Luker
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
IJMS  2020 , 21 (14), 5064. https://doi.org/10.3390/ijms21145064 . (7)        Lu, D.; Immadi, S. 324–335. https://doi.org/10.1038/s41401-018-0164-x . (8)        Gado, F.; Di Cesare Mannelli, L.; Lucarini 376  (3), 235–242. https://doi.org/10.1056/NEJMoa1610300 . (10)     Rosado, T.; Gonçalves ,Joana; LuĂs
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
A standard format of GPCR biosensors incorporates a luminescent tag on the G protein Gα subunit and Gβγ Modifying G proteins with luminescent tags as used in biosensors altered the G protein coupling profiles R luc: Renilla  luciferase, GFP: Green Fluorescent Protein. Wouters OJ, McKee M, Luyten J. Lu S, He X, Ni D, Zhang J.
- đź“° GPCR Weekly News, May 1 to 7, 2023
Jack Antel to its clinical advisory board Crinetics Pharmaceuticals First Quarter 2023 Earnings: Revenues
- Choosing the Right GPCR Calcium Assay Readout for Measuring Receptor Activation
Unlike fluorescent methods, aequorin produces luminescent signals with very low background noise and This allows researchers to perform either fluorescent or luminescent calcium measurements depending on Calcium dose response curve in luminescence mode for the ChemiBRITE GLP-1 Receptor Ready-to-Assay Frozen
- Amylin Receptor Signaling: Three Receptors From One, and How to Profile Each
changes intracellular cAMP, detected through an enzyme fragment complementation readout that produces a luminescent β-arrestin recruitment to the activated receptor, bringing two enzyme fragments together to produce a luminescent
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
In this proximity-based approach, a NanoLuc®luciferase  genetically fused  to the target protein  transfers
- How Collaboration Drives GPCR Discoveries
In research, including the GPCR world collaboration isn’t a luxury. It’s survival.
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
The Quick Glance: pA₂ as Shortcut Sometimes, discovery projects don’t have the luxury of full curve analyses
- How GPCR Collaboration Built an Innovation Engine
This wasn’t luck. It was designed. “There was a bit of luck,” she admits. But luck alone doesn’t sustain an ecosystem. What mattered was how leadership leveraged luck into durable structure  — through funding strategies, It’s a competitive advantage. 🎧 Listen to the full episode:  Leadership, Luck, and GPCR Signaling 🔓
- From Pipettes to Platforms: The Evolution of GPCR Research
Leadership, Luck, and the Lab The episode isn’t just about technology — it’s also about how careers are
- How GPCR Spatial Signaling Sparked a Scientific Journey
Luck, Leadership & GPCR Signaling Michelle is clear: luck played a role. But so did choice. It’s easy to call it luck. But luck only works if you say yes when the door opens.
- Innovative Data-Driven Solutions: The pHSense Revolution
This success was not mere luck.
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
Pipeline efficiency isn’t luck—it’s literacy.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
It wasn’t luck. It was persistence.
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
challenges Decades of insight distilled  into frameworks you can apply immediately Pipeline efficiency isn’t luck—it
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Luc Van Hijfte and Dr. Wendy Young.
- Conjugation Strategies for Probe Development
This is LucĂa from the Celtarys Research chemistry team.Â
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
outputs into a central hub — where QC, analysis, consumption and consolidation across assays — isn’t a luxury
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
“The first time I wore my lucky cactus shirt to a major meeting... and it led to a game-changing collaboration























